Risk Factors for Acute Rheumatic Fever: Literature Review and Protocol for a Case-Control Study in New Zealand.

Teuila Percival, Diana Lennon, Barry Gribben, Angela Chong, Florina Chan Mow, Lyndie Foster Page, Richard Edwards, Catherine Jackson, Colleen Murray, Michael G Baker, Tony R Merriman, Nigel Wilson, Nevil Pierse, Deborah A Williamson, Nicole J Moreland, Jane Oliver, Jason Gurney

Journal: International journal of environmental research and public health 2020;16(22):4515

PMID: 31731673

Abstract

Acute rheumatic fever (ARF) and its sequela, rheumatic heart disease (RHD), have largely disappeared from high-income countries. However, in New Zealand (NZ), rates remain unacceptably high in indigenous Māori and Pacific populations. The goal of this study is to identify potentially modifiable risk factors for ARF to support effective disease prevention policies and programmes. A case-control design is used. Cases are those meeting the standard NZ case-definition for ARF, recruited within four weeks of hospitalisation for a first episode of ARF, aged less than 20 years, and residing in the North Island of NZ. This study aims to recruit at least 120 cases and 360 controls matched by age, ethnicity, gender, deprivation, district, and time period. For data collection, a comprehensive pre-tested questionnaire focussed on exposures during the four weeks prior to illness or interview will be used. Linked data include previous hospitalisations, dental records, and school characteristics. Specimen collection includes a throat swab (Group A Streptococcus), a nasal swab (Staphylococcus aureus), blood (vitamin D, ferritin, DNA for genetic testing, immune-profiling), and head hair (nicotine). A major strength of this study is its comprehensive focus covering organism, host and environmental factors. Having closely matched controls enables the examination of a wide range of specific environmental risk factors.

Address: Department of Public Health, University of Otago, Wellington 6021, New Zealand.; School of Medical Sciences, University of Auckland, Auckland 1010, New Zealand.; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, University of Melbourne at The Doherty Institute for Infection and Immunity, Melbourne 3010, Australia.; Green Lane Paediatric and Congenital Cardiac Services, Starship Children's Hospital, Auckland District Health Board, Auckland 1023; New Zealand.; Department of Paediatrics, University of Auckland, Auckland 1142, New Zealand.; Biochemistry Department, University of Otago, Dunedin 9054, New Zealand.; School of Population Health, University of Auckland, Auckland 1142, New Zealand.; KidzFirst Children's Hospital, Auckland 1640, New Zealand.; Faculty of Dentistry, University of Otago, Dunedin 9054, New Zealand.; Auckland Regional Public Health Service, Auckland District Health Board, Auckland 0622, New Zealand.; CBG Health Research Ltd, Auckland 0651, New Zealand.; Starship Children's Hospital, Auckland District Health Board, Auckland 1023, New Zealand.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.